A 14-Day Study of Racivir When Used in Combination in HIV-Infected Males

Inclusion Criteria Subjects may be eligible to participate if they: Are males with HIV infection with a positive HIV antibody test Have an HIV-RNA copy number of ≥ 5000 copies/ml (Roche assay) Have CD4+ cell counts ≥ 50 cells/ml Are 18-45 years of age, inclusive Have a body mass index (BMI) ≥ 18 kg/m2 Are antiretroviral nucleoside reverse transcriptase inhibitor-naive Have read and understand the informed consent,and is able and willing to comply with study procedures Exclusion Criteria Subjects may not participate if they: Have clinically significant ECG abnormalities Have clinically significant abnormalities in any safety laboratory parameters Have an ALT value ≥ 3xUNL Have previously participated in this trial Have participated in another trial of an investigational drug within the last 3 months or are currently participating in another trial of an investigational drug Have a history of chronic alcohol or drug abuse within the last 6 months Have a positive urine drug screening Have a positive alcohol breath test Have any medical or psychiatric condition, which in the opinion of the investigator would jeopardize or compromise the subject's ability to participate in this trial Have a known hypersensitivity to any components of the trial medication or comparative drugs as stated in this protocol